MLchartDataset catalogue

Isoniazid

Term · Oncology and biomedicine · MLC-T-ONC-014590

A synthetic derivative of nicotinic acid with anti-mycobacterial properties. Although its mechanism of action is still unclear, isoniazid appears to block the synthesis of mycolic acids, major components of the mycobacterial cell wall. This agent is only active against actively growing mycobacteria because, as a pro-drug, it requires activation in susceptible mycobacterial species. Isoniazid also interferes with mycobacterial metabolism of vitamin B6. Resistance occurs due to decreased bacterial wall penetration.

Table 1. Record
IdentifierMLC-T-ONC-014590
FieldOncology and biomedicine
AbbreviationINH
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014590",
  "term": "Isoniazid",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic derivative of nicotinic acid with anti-mycobacterial properties. Although its mechanism of action is still unclear, isoniazid appears to block the synthesis of mycolic acids, major components of the mycobacterial cell wall. This agent is only active against actively growing mycobacteria because, as a pro-drug, it requires activation in susceptible mycobacterial species. Isoniazid also interferes with mycobacterial metabolism of vitamin B6. Resistance occurs due to decreased bacterial wall penetration.",
  "abbreviation": "INH",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/isoniazid/"
}

Record 9,624 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.